Clinical Trials · NCT07092605
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
- Phase
- EARLY_Phase 1
- Recruitment status
- Enrolling By Invitation
- Sponsor
- AgelessRx
- Enrollment
- 150
- Start date
- Nov 2024
- Locations
- 1 site, United States
- Primary endpoint
- Change in self-reported pain levels in participants microdosing GLP1s